-transparent.png){kind=logo}
One mg of glucagon was given subcutaneously to eight patients with active acromegaly. Seven out of eight patients had a rapid decrease in serum growth hormone (GH) levels at 30 min after the glucagon injection. In two out of seven patients a rebound increase in serum GH following the early GH reduction was observed. On the other hand, oral administration of 50 g glucose which caused a comparable increase in blood glucose to that after the glucagon injection elicited no early suppression in serum GH levels in the same patients. These data suggest that the inhibition of GH release induced by glucagon could not be related to the increase in blood glucose by glucagon.
Related Publications
J Takahara, and
H Hosogi, and
J Yamauchi, and
N Ogawa, and
T Ofuji
October 1988,
Zhonghua yi xue za zhi = Chinese medical journal; Free China ed,
J Takahara, and
H Hosogi, and
J Yamauchi, and
N Ogawa, and
T Ofuji
November 1976,
Clinical endocrinology,
J Takahara, and
H Hosogi, and
J Yamauchi, and
N Ogawa, and
T Ofuji
September 1992,
Journal of internal medicine,
J Takahara, and
H Hosogi, and
J Yamauchi, and
N Ogawa, and
T Ofuji
July 1986,
The Journal of clinical endocrinology and metabolism,
J Takahara, and
H Hosogi, and
J Yamauchi, and
N Ogawa, and
T Ofuji
December 1993,
Atherosclerosis,
J Takahara, and
H Hosogi, and
J Yamauchi, and
N Ogawa, and
T Ofuji
March 2020,
The Journal of clinical endocrinology and metabolism,
J Takahara, and
H Hosogi, and
J Yamauchi, and
N Ogawa, and
T Ofuji
April 1977,
British medical journal,
J Takahara, and
H Hosogi, and
J Yamauchi, and
N Ogawa, and
T Ofuji
August 1967,
JAMA,
J Takahara, and
H Hosogi, and
J Yamauchi, and
N Ogawa, and
T Ofuji
April 1974,
The New England journal of medicine,
J Takahara, and
H Hosogi, and
J Yamauchi, and
N Ogawa, and
T Ofuji
September 1984,
Research communications in chemical pathology and pharmacology,
